Evolve BioSystems (Evivo)

Evivo (activated B. infantis EVC001) is the first and only infant probiotic clinically demonstrated to functionally metabolize human milk oligosaccharides to improve the biochemistry of the infant gut. Through the specific symbiotic mechanism with human milk, Evivo is clinically proven to reduce potential gut pathogens, decrease intestinal inflammation, positively impact health outcomes, and improve immune development in infants. Evivo is recommended by thousands of pediatric healthcare providers for at-home feeding. Evivo with MCT Oil is used as a standard of care in NICUs across the U.S. To learn more about recommending Evivo for your patients visit Evivo.com/professional

Product Theater
Sunday, Oct. 10 
12 – 12:30 p.m. CDT
Proactive Management of the Infant Gut Improves Short- and Long-Term Health Outcomes